338P - Real-world effectiveness of first-line palbociclib + letrozole for metastatic breast cancer 4 years post approval in the US
| Autor: | Kish, J., Trocio, J., Miller, T., Nero, D., Liassou, D., Liu, X., McRoy, L., Feinberg, B. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v120-v121 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|